Swidar (Fansidar) Tablets

Effective Antimalarial Treatment for Pregnancy and Acute Cases

Overview

Swidar Tablets, manufactured by Swiss Pharma Nigeria Limited (Swipha), is a trusted antimalarial medication. It contains a fixed-dose combination of Sulfadoxine (500mg) and Pyrimethamine (25mg). In Nigeria, Swidar is widely recognized as a high-quality local equivalent to the global brand Fansidar.

Key Uses

• Intermittent Preventive Treatment in pregnancy (IPTp): Swidar is primarily used in Nigerian clinical guidelines to prevent malaria-related complications in pregnant women.
• Treatment of Malaria: It is effective for treating acute, uncomplicated malaria, particularly in cases where resistance to older antimalarials is suspected.

How it Works

As an antifolate combination, Swidar works by inhibiting the enzymes responsible for folic acid biosynthesis in malaria parasites like Plasmodium falciparum. This prevents the parasites from multiplying, providing effective relief from infection symptoms.

Recommended Dosage

For the treatment of malaria in adults, a single dose of 3 tablets is typically administered. For IPTp in pregnancy, the dosage and timing should be strictly supervised by a healthcare professional or as part of antenatal care.

Safety and Side Effects

While generally well-tolerated, some users may experience side effects such as skin rashes or nausea. It should not be used by individuals with a known sulfa allergy or severe kidney or liver issues. Always consult a GoMed pharmacist if you have concerns about "side effects of Swidar in pregnancy".

Comparison: Swidar vs Fansidar

Many customers ask, "Is Swidar same as Fansidar?". The answer is yes. Swidar is the Nigerian-manufactured version of the combination drug originally known as Fansidar, containing identical active ingredients and offering the same therapeutic benefits.